🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareComparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide — need advice Page 5

Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide — need advice

emily_PDX Mon, Jul 22, 2024 at 4:07 PM 36 replies 2,470 viewsPage 5 of 8
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jul 22, 2024 at 11:12 PM#21

Congrats emily_PDX!! You should be so proud of yourself. 🎉

16 9PharmHunterJen, TomTeleRx, DoseLogDan and 13 others
Reply Quote Save Share Report
ZaraB_AL
Member
456
1,678
Jan 2025
Alabama
Jul 22, 2024 at 11:29 PM#22

Reading this thread on Comparative hits close to home. Dad of 2 checking in — I started at 273 lbs and felt like I would tried everything.

9 months on tirz and I am a different person. Not just the 48 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Comparative — take the leap. It was the best health decision I have ever made. ❤️

8 10KevinCompounds, TirzTom, TrialTracker_MD and 5 others
Reply Quote Save Share Report
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Jul 22, 2024 at 11:46 PM#23

As a healthcare provider, I want to add some clinical context to this discussion on Comparative pharmacokinetics semaglutide.

Building on what mike_mod said — the evidence base here is well-established. The key publications to reference are from the FLOW program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
32 13LarryQC_SD, wanda_boise, NurseAsh_DET and 29 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Jul 23, 2024 at 12:03 AM#24

ZaraB_AL — wow. This community is amazing.

Last edited: Jul 23, 2024 at 1:03 AM
7 17VendorMark, COA_Karl, MikeFit_NJ and 4 others
Reply Quote Save Share Report
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
Jul 23, 2024 at 12:20 AM#25

Adding my data to this Comparative discussion:

MetricBaselineMonth 5Month 8
Weight266 lbs241 lbs221 lbs
A1C7.0%6.0%5.4%
hsCRP5.04.00.8

Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.3g/kg/day.

41 15EndoResFellow, PharmacoVig_BOS, SurmountFan_IN and 38 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register